Company Filing History:
Years Active: 2019-2025
Title: Innovations in Photodynamic Therapy by Hans-Ulrich Reißig
Introduction
Hans-Ulrich Reißig is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of photodynamic therapy through his innovative research and patents. With a total of 2 patents, his work focuses on biologically active compounds that serve as photosensitizers for various medical applications.
Latest Patents
Reißig's latest patents involve specifically meso-substituted porphyrins and chlorins designed for photodynamic therapy. These compounds are intended for diagnostic and therapeutic applications, particularly in treating cancer, infections, and other hyperproliferative diseases. His patents detail methods for synthesizing porphyrins with defined arrangements of meso-substituents, converting them into chlorin systems, and formulating these compounds into pharmaceutical preparations. The innovations aim to enhance the efficacy of photodynamic therapy while addressing issues such as solubility and pharmacokinetics.
Career Highlights
Hans-Ulrich Reißig is associated with Biolitec Unternehmensbeteiligungs II AG, where he continues to advance his research in photodynamic therapy. His work has garnered attention for its potential to improve treatment outcomes for various medical conditions.
Collaborations
Some of his notable coworkers include Hartwig Richard Arthur Golf and Arno Wiehe, who have contributed to his research endeavors.
Conclusion
Hans-Ulrich Reißig's innovative work in photodynamic therapy exemplifies the intersection of chemistry and medicine, showcasing the potential of his patented compounds to revolutionize treatment methodologies.